| Literature DB >> 30425677 |
Jiani Chen1, Xintong Wu1, Yongqiao He2, Sisi Li1, Yongyi Deng2, Jie Chen2, Wenyu Fang2, Zhamu Zeren2, Jianmei Peng2, Yingjuan Li2, Jie Mu1, Dong Zhou1.
Abstract
Background: There is limited detailed clinical information for patients with epilepsy in Tibet. This study sought to provide data about the clinical features of epilepsy in the Ganzi Tibetan Autonomous Prefecture to improve strategies for epilepsy prevention and management in this region.Entities:
Keywords: Ganzi Tibetan Autonomous Prefecture; cerebral infection; clinical features and atiology; epilepsy; retrospective study
Year: 2018 PMID: 30425677 PMCID: PMC6218953 DOI: 10.3389/fneur.2018.00891
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Demographic features of PWEs in the neurology department of Ganzi people's hospital and control group from West China hospital.
| Gender, | – | – | 1.000 |
| Female | 69 (41.8%) | 69(41.8%) | – |
| Male | 96 (58.2%) | 96 (58.2%) | – |
| Age (year, mean ± SD) | 39.4 ± 16.8 | 40.0 ± 17.0 | 0.721 |
| Age group, | – | – | 0.996 |
| ≤14 years | 5 (3.0%) | 5 (3.0%) | – |
| 15–44 years | 99 (60.0%) | 97 (58.8%) | – |
| 45–59 years | 37 (22.5%) | 38 (23.0%) | – |
| ≥60 years | 24 (14.5%) | 25 (15.2%) | – |
| Marriage, | – | – | 0.729 |
| Married | 109 (66.1%) | 106 (64.2%) | – |
| Single | 56 (33.9%) | 59 (35.8%) | – |
| Living area, | – | – | 0.000 |
| Urban | 41 (24.8%) | 105 (63.6%) | – |
| Rural/pastoral | 124 (75.2%) | 60 (36.4%) | – |
| Education status, | – | – | 0.000 |
| Illiterate | 104 (63.0%) | 2 (1.2%) | – |
| Primary school and middle school | 38 (23.0%) | 77 (46.7%) | – |
| High school | 15 (9.1%) | 37 (22.4%) | – |
| College | 8 (4.8%) | 49 (29.7%) | – |
| Job, | – | – | 0.000 |
| Not employed | 9 (5.5%) | 41 (24.8%) | – |
| Student | 17 (10.3%) | 26 (15.8%) | – |
| Farmer | 100 (60.6%) | 30 (18.2%) | – |
| Employment | 21 (12.7%) | 46 (27.8%) | – |
| Retirement | 7 (4.2%) | 11 (6.7%) | – |
| Other | 11 (6.7%) | 11 (6.7%) | – |
| Ethnic Group, | – | – | 0.000 |
| Han | 34 (20.6%) | 158 (95.8%) | – |
| Tibetan | 128 (77.6%) | 5 (3.0%) | – |
| Yi | 3 (1.8%) | 2 (1.2%) | – |
P < 0.05.
Fisher exact test.
Including housewife.
Clinical features of PWEs in neurology department of Ganzi people's hospital and control group from West China hospital.
| Age of onset (year, mean ± SD) | 34.5 ± 18.0 | 31.9 ± 19.0 | 0.208 |
| Admitted for status epilepticus, | 33 (20.0%) | 17 (10.3%) | 0.014 |
| Death after status epilepticus | 2 (6.1%) | 0 (0%) | 0.517 |
| Newly diagnosis | 104 (63.0%) | 55 (33.3%) | 0.000 |
| Seizure type, | – | – | 0.087 |
| Generalized onset | 47 (28.5%) | 66 (40%) | – |
| Tonic-clonic | 46 (27.9%) | 65 (39.4%) | – |
| Nonmotor | 1 (0.6%) | 1 (0.6%) | – |
| Focal onset | 113 (68.5%) | 95 (57.6%) | – |
| Impaired awareness | 12 (7.3%) | 32 (19.4%) | – |
| Aware | 5 (3.0%) | 7 (4.2%) | – |
| Focal to bilateral tonic-clonic | 96 (58.2%) | 56 (33.9%) | – |
| Unknown onset | 5 (3.0%) | 4 (2.4%) | – |
| EEG, | 51 (30.9%) | 151 (91.5%) | 0.001 |
| Normal | 19 (37.3%) | 87 (57.6%) | – |
| Non-specific abnormality | 5 (9.8%) | 26 (17.2%) | – |
| Epileptiform discharge | 27 (52.9%) | 38 (25.2%) | – |
| MRI/CT scan, | – | – | 0.000 |
| Abnormal | 102 (61.8%) | 63 (38.2%) | – |
| Normal | 61 (37.0%) | 100 (60.6%) | – |
| Anti-epileptic drugs at the time of discharge, | – | – | 0.000 |
| No treatment | 18 (10.9%) | 24 (14.5%) | – |
| Mono-therapy | 129 (78.2%) | 90 (54.5%) | – |
| Poly-therapy | 18 (10.9%) | 51 (31.0%) | – |
P < 0.05.
Haldane–Anscombe correction.
Fisher exact test.
General etiologic features of the epilepsy patients.
| Infectious | 41 (24.8%) | 12 (7.3%) | 4.216 (2.124–8.367) |
| Neurocysticercosis | 13 (7.9%) | 0 (0.0%) | 29.301 (1.727–497.167) |
| Brain hydatidosis | 11 (6.7%) | 0 (0.0%) | 24.637 (1.439–421.670) |
| Tuberculous | 9 (5.5%) | 3 (1.8%) | 3.115 (0.828–11.721) |
| Viral infection | 6 (3.6%) | 8 (4.8%) | 0.740 (0.251–2.183) |
| Brain abcess | 2 (1.2%) | 1 (0.6%) | 1.974 (0.177–22.001) |
| Structural | 65 (39.4%) | 60 (36.4%) | 1.137 (0.728–1.775) |
| Head trauma | 34 (20.6%) | 19 (11.5%) | 1.994 (1.084–3.666) |
| Stroke | 18 (10.9%) | 11 (6.7%) | 1.714 (0.783–3.752) |
| Ischemic | 11 (6.7%) | 5 (3.0%) | 2.285 (0.776–6.731) |
| Hemorrhage | 7 (4.2%) | 6 (3.6%) | 1.174 (0.386–3.571) |
| Cerebral tumor | 3 (1.8%) | 6 (3.6%) | 0.490 (0.120–1.996) |
| Hippocampus sclerosis | 1 (0.6%) | 10 (6.0%) | 0.094 (0.012–0.747) |
| Cortical dysplasia | 4 (2.4%) | 8 (4.8%) | 0.487 (0.143–1.651) |
| Unclear intracranial space-occupying lesions | 5 (3.0%) | 3 (1.8%) | 1.687 (0.396–7.179) |
| Other structural changes | 0 (0.0%) | 3 (1.8%) | 0.143 (0.007–2.737) |
| Metabolic | 0 (0.0%) | 0 (0.0%) | 1.000 (0.019–50.699) |
| Immune | 2 (1.2%) | 3 (1.8%) | 0.662 (0.109–4.018) |
| Presumed genetic cause | 8 (4.8%) | 17 (10.3%) | 0.443 (0.186–1.058) |
| Unknown | 49 (29.7%) | 73 (44.2%) | 0.532 (0.338–0.838) |
P < 0.05.
Haldane–Anscombe correction.
Autoimmune encephalitis.
Included Genetic Generalized Epilepsies.